Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Change in Inventory (2016 - 2018)

Theravance Biopharma (TBPH) has disclosed Change in Inventory for 6 consecutive years, with $1.1 million as the latest value for Q4 2018.

  • Quarterly Change in Inventory fell 75.17% to $1.1 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2018, down 77.69% year-over-year, with the annual reading at $1.6 million for FY2018, 77.69% down from the prior year.
  • Change in Inventory for Q4 2018 was $1.1 million at Theravance Biopharma, up from $201000.0 in the prior quarter.
  • The five-year high for Change in Inventory was $4.3 million in Q4 2017, with the low at -$912000.0 in Q4 2015.
  • Average Change in Inventory over 5 years is $885500.0, with a median of $306000.0 recorded in 2015.
  • The sharpest move saw Change in Inventory surged 7096.15% in 2014, then plummeted 542.72% in 2015.
  • Over 5 years, Change in Inventory stood at $206000.0 in 2014, then tumbled by 542.72% to -$912000.0 in 2015, then soared by 247.37% to $1.3 million in 2016, then surged by 222.77% to $4.3 million in 2017, then crashed by 75.17% to $1.1 million in 2018.
  • According to Business Quant data, Change in Inventory over the past three periods came in at $1.1 million, $201000.0, and -$20000.0 for Q4 2018, Q3 2018, and Q2 2018 respectively.